CNTX 8-K 2026-07-31

Context Therapeutics Inc. (CNTX) 8-K dated 2026-07-31 — accession 0001628280-26-051399.

Context Therapeutics Inc. (CNTX) is a biotechnology company listed on NASDAQ.

Context Therapeutics Inc. filed a 8-K on 2026-07-31. Accession 0001628280-26-051399.

This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for CNTX is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The CNTX SEC hub lists recent forms. The stock page is the research view.